Supplemental material
Modern Rheumatology
Volume 30, 2020 - Issue 4
Related Research Data
Factors influencing physician decisions to discontinue treatment after onset of liver dysfunction: Post-hoc analysis of an all-case post-marketing surveillance study of iguratimod
Source:
Taylor & Francis
Factors influencing physician decisions to discontinue treatment after onset of liver dysfunction: Post-hoc analysis of an all-case post-marketing surveillance study of iguratimod
Source:
Taylor & Francis
Linking provided by
